New clinical trial data demonstrates bd libertas™ wearable injector as a drug delivery system

Franklin lakes, n.j., dec. 9, 2020 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced publication of the results from a 52-subject human clinical trial with the bd libertas™ wearable injector. the subcutaneous drug...
BDX Ratings Summary
BDX Quant Ranking